dr von hoff has mentioned the gem/abraxane trial, but not the su2c triple since 2010, if i'm not mistaken. i assume the reason he hasn't is because that information would be controlled by genentech and roche. the question is, will genentech announce preliminary results of the triple before, during, or after the su2c event on 9/7? i looked at the emo sept meeting link that big provided and quickly found two pancreatic discussion on 9/28 1100-1230 and 10/1 1100-1230. neither mentioned a specific treatment.
good question. we have always known this was out there, but i haven't paid much attention to it because the nci is involved. and i think we have a few nci studies way past due that they have not reported on, but that is no excuse for me. anyway, we should look forward to results, but who knows when?